Report error Found 4176 with Last Name = 'zhong' and Initial = 'w'
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.29E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.78E+4nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.11E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 830nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 780nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 5.23E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 600nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 170nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 800nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.02E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.12E+4nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 560nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.28E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.77E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 760nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 820nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 7.19E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 980nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 7.75E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 8.42E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.77E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 530nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 2.76E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 1.86E+3nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 130nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
TargetHypoxia-inducible factor 1-alpha(Human)
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China
US Patent
Affinity DataEC50: 4.14E+4nMAssay Description:The compounds were formulated with DMSO to form 30 mM stock solutions, and then formulated with analytical nutrient solution to form 2× working solut...More data for this Ligand-Target Pair
Affinity DataKd: 1.81nMAssay Description:Example 40: In the experiment, the instrument OctectRED of Fortebio Company based on biofilm interferometry (BLI) technology was used to capture huma...More data for this Ligand-Target Pair
Affinity DataKd: 0.0160nMAssay Description:Example 40: In the experiment, the instrument OctectRED of Fortebio Company based on biofilm interferometry (BLI) technology was used to capture huma...More data for this Ligand-Target Pair
Affinity DataKd: 0.296nMAssay Description:Example 40: In the experiment, the instrument OctectRED of Fortebio Company based on biofilm interferometry (BLI) technology was used to capture huma...More data for this Ligand-Target Pair
Affinity DataKd: 0.515nMAssay Description:Example 40: In the experiment, the instrument OctectRED of Fortebio Company based on biofilm interferometry (BLI) technology was used to capture huma...More data for this Ligand-Target Pair
Affinity DataKd: 67.5nMAssay Description:Example 40: In the experiment, the instrument OctectRED of Fortebio Company based on biofilm interferometry (BLI) technology was used to capture huma...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Beijing Institute of Pharmacology and Toxicology
Curated by ChEMBL
Beijing Institute of Pharmacology and Toxicology
Curated by ChEMBL
Affinity DataEC50: 3.63E+3nMAssay Description:Inhibition of HIV1 envelope glycoprotein-mediated cell-cell fusion between HL2/3 cells stably expressing HIV Gag, Env, Tat, Rev and Nef proteins and ...More data for this Ligand-Target Pair
Affinity DataEC50: 1.02E+3nMAssay Description:Inhibition of Ebola virus Sudan envelope glycoprotein-mediated cell entry in human HuH7 cells treated with 30 mins pre-treated pseudovirus/compopund ...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
Affinity DataEC50: 4.30nMAssay Description:Agonist activity at human adenosine receptor A2A expressed in HEK293 cells assessed as cAMP accumulation incubated for 30 mins by Eu-cAMP tracer-base...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
Affinity DataEC50: 15nMAssay Description:Agonist activity at human adenosine receptor A2A expressed in HEK293 cells assessed as cAMP accumulation incubated for 30 mins by Eu-cAMP tracer-base...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
Affinity DataEC50: 18nMAssay Description:Agonist activity at human adenosine receptor A2A expressed in HEK293 cells assessed as cAMP accumulation incubated for 30 mins by Eu-cAMP tracer-base...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
Affinity DataEC50: 4.60nMAssay Description:Agonist activity at human adenosine receptor A2A expressed in HEK293 cells assessed as cAMP accumulation incubated for 30 mins by Eu-cAMP tracer-base...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
Affinity DataEC50: 5.5nMAssay Description:Agonist activity at human adenosine receptor A2A expressed in HEK293 cells assessed as cAMP accumulation incubated for 30 mins by Eu-cAMP tracer-base...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
Affinity DataEC50: 1.40nMAssay Description:Agonist activity at human adenosine receptor A2A expressed in HEK293 cells assessed as cAMP accumulation incubated for 30 mins by Eu-cAMP tracer-base...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
Affinity DataEC50: 0.640nMAssay Description:Agonist activity at human adenosine receptor A2A expressed in HEK293 cells assessed as cAMP accumulation incubated for 30 mins by Eu-cAMP tracer-base...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
Affinity DataEC50: 4.10nMAssay Description:Agonist activity at human adenosine receptor A2A expressed in HEK293 cells assessed as cAMP accumulation incubated for 30 mins by Eu-cAMP tracer-base...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
Affinity DataEC50: 1.10nMAssay Description:Agonist activity at human adenosine receptor A2A expressed in HEK293 cells assessed as cAMP accumulation incubated for 30 mins by Eu-cAMP tracer-base...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
Affinity DataEC50: 5.70nMAssay Description:Agonist activity at human adenosine receptor A2A expressed in HEK293 cells assessed as cAMP accumulation incubated for 30 mins by Eu-cAMP tracer-base...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
Affinity DataEC50: 8.5nMAssay Description:Agonist activity at human adenosine receptor A2A expressed in HEK293 cells assessed as cAMP accumulation incubated for 30 mins by Eu-cAMP tracer-base...More data for this Ligand-Target Pair
TargetAdenosine receptor A2a(Human)
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
National Engineering Research Center For The Emergency Drug
Curated by ChEMBL
Affinity DataEC50: 10nMAssay Description:Agonist activity at human adenosine receptor A2A expressed in HEK293 cells assessed as cAMP accumulation incubated for 30 mins by Eu-cAMP tracer-base...More data for this Ligand-Target Pair
TargettRNA (guanine-N(1)-)-methyltransferase(Staphylococcus aureus (strain NCTC 8325 / PS 47))
Singapore-Mit Alliance For Research and Technology
Curated by ChEMBL
Singapore-Mit Alliance For Research and Technology
Curated by ChEMBL
Affinity DataKd: 3.10E+3nMAssay Description:Binding affinity to full length Staphylococcus aureus tRNA (guanine(37)-N1)-methyltransferase expressed in Escherichia coli BL21 (DE3) by surface pla...More data for this Ligand-Target Pair
TargettRNA (guanine-N(1)-)-methyltransferase(Mycobacterium tuberculosis (strain ATCC 25618 / H3...)
Singapore-Mit Alliance For Research and Technology
Curated by ChEMBL
Singapore-Mit Alliance For Research and Technology
Curated by ChEMBL
Affinity DataKd: 1.04E+4nMAssay Description:Binding affinity to full length Mycobacterium tuberculosis tRNA (guanine(37)-N1)-methyltransferase expressed in Escherichia coli BL21 (DE3) by surfac...More data for this Ligand-Target Pair
3D Structure (crystal)TargettRNA (guanine-N(1)-)-methyltransferase(Mycobacterium tuberculosis (strain ATCC 25618 / H3...)
Singapore-Mit Alliance For Research and Technology
Curated by ChEMBL
Singapore-Mit Alliance For Research and Technology
Curated by ChEMBL
Affinity DataKd: 190nMAssay Description:Binding affinity to full length Mycobacterium tuberculosis tRNA (guanine(37)-N1)-methyltransferase expressed in Escherichia coli BL21 (DE3) by surfac...More data for this Ligand-Target Pair
TargettRNA (guanine-N(1)-)-methyltransferase(Mycobacterium tuberculosis (strain ATCC 25618 / H3...)
Singapore-Mit Alliance For Research and Technology
Curated by ChEMBL
Singapore-Mit Alliance For Research and Technology
Curated by ChEMBL
Affinity DataKd: 1.01E+4nMAssay Description:Binding affinity to full length Mycobacterium tuberculosis tRNA (guanine(37)-N1)-methyltransferase expressed in Escherichia coli BL21 (DE3) by surfac...More data for this Ligand-Target Pair
TargettRNA (guanine-N(1)-)-methyltransferase(Staphylococcus aureus (strain NCTC 8325 / PS 47))
Singapore-Mit Alliance For Research and Technology
Curated by ChEMBL
Singapore-Mit Alliance For Research and Technology
Curated by ChEMBL
Affinity DataKd: 3.30E+3nMAssay Description:Binding affinity to full length Staphylococcus aureus tRNA (guanine(37)-N1)-methyltransferase expressed in Escherichia coli BL21 (DE3) by surface pla...More data for this Ligand-Target Pair
